Project Lead: Dr John Cafferkey

Procalcitonin is a marker of bacterial infection which can be measured in the blood. It is a relatively new test which is already used in some hospitals, mostly to help doctors understand what is causing severe infections.

We used this test during the COVID-19 pandemic because some data suggested it shows how unwell someone might become in the early stages of COVID-19. It could also be useful to identify patients who have bacterial infections on top of the COVID-19 disease or give doctors a measure of whether the disease is becoming more severe.

We want to find out whether this test was accurate, and whether it added important information beyond some of the more commonplace tests we do in the hospital. Understanding this will help us decide whether we should carry on doing the test in the future.

Other Projects

Rehabilitation for patients with COVID-19 admitted to hospital: predictors and outcomes Dr Susan Shenkin Covid-19 Project

Many people with COVID-19 recover quickly and return home, soon able to return to their normal level of function. However, some people become very unwell ...
Read More

Utilisation and value of procalcitonin testing in NHS Lothian patients during the COVID-19 pandemic Dr Sara Jenks Covid-19 Project

Procalciton in is a marker of bacterial infection which can be measured in the blood. Data has shown it is able to be used as a prognostic marker in COVID...
Read More